RALGDS
Basic information
Region (hg38): 9:133097720-133149334
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RALGDS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 12 | 25 | |||
missense | 50 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 51 | 20 | 13 |
Variants in RALGDS
This is a list of pathogenic ClinVar variants found in the RALGDS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-133098600-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
9-133098609-T-C | not specified | Uncertain significance (Dec 07, 2023) | ||
9-133098621-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
9-133098651-C-G | not specified | Uncertain significance (Mar 29, 2022) | ||
9-133098652-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
9-133098653-G-A | Likely benign (Jun 20, 2018) | |||
9-133098737-G-A | Likely benign (Dec 26, 2018) | |||
9-133098745-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
9-133100311-C-T | Benign (Dec 31, 2019) | |||
9-133100327-T-C | not specified | Uncertain significance (Oct 20, 2023) | ||
9-133100365-C-T | Uncertain significance (Oct 01, 2016) | |||
9-133101552-C-G | not specified | Uncertain significance (Dec 28, 2023) | ||
9-133101589-C-T | Benign (Dec 31, 2019) | |||
9-133101634-T-C | Likely benign (Feb 01, 2023) | |||
9-133101663-C-T | not specified | Likely benign (Dec 13, 2023) | ||
9-133101729-T-A | not specified | Uncertain significance (Mar 07, 2024) | ||
9-133101736-G-A | Likely benign (Feb 12, 2018) | |||
9-133101966-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
9-133101970-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
9-133101994-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
9-133101995-G-A | Benign (May 20, 2018) | |||
9-133102013-G-A | Benign (Dec 31, 2019) | |||
9-133102017-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
9-133102039-C-T | not specified | Uncertain significance (Jan 25, 2023) | ||
9-133102048-C-T | not specified | Uncertain significance (Aug 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RALGDS | protein_coding | protein_coding | ENST00000372050 | 18 | 66195 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.888 | 0.112 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.47 | 424 | 518 | 0.819 | 0.0000339 | 5846 |
Missense in Polyphen | 68 | 86.103 | 0.78975 | 981 | ||
Synonymous | -1.23 | 247 | 224 | 1.10 | 0.0000162 | 1869 |
Loss of Function | 4.89 | 8 | 42.4 | 0.189 | 0.00000200 | 511 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.000437 | 0.000435 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000711 | 0.0000703 |
Middle Eastern | 0.000437 | 0.000435 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Stimulates the dissociation of GDP from the Ras-related RalA and RalB GTPases which allows GTP binding and activation of the GTPases. Interacts and acts as an effector molecule for R-Ras, H-Ras, K-Ras, and Rap.;
- Pathway
- Choline metabolism in cancer - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Human Thyroid Stimulating Hormone (TSH) signaling pathway;Chromosomal and microsatellite instability in colorectal cancer;Ras Signaling;EGF-EGFR Signaling Pathway;Signal Transduction;ras signaling pathway;p38MAPK events;Signalling to RAS;Signalling to ERKs;Signaling by NTRK1 (TRKA);Signaling by NTRKs;EGFR1;ErbB1 downstream signaling;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.161
Intolerance Scores
- loftool
- 0.515
- rvis_EVS
- -1.34
- rvis_percentile_EVS
- 4.64
Haploinsufficiency Scores
- pHI
- 0.482
- hipred
- Y
- hipred_score
- 0.695
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ralgds
- Phenotype
- neoplasm; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- Ras protein signal transduction;regulation of catalytic activity
- Cellular component
- nucleus;cytosol;brush border
- Molecular function
- guanyl-nucleotide exchange factor activity;protein binding;GTPase regulator activity